Douglas Earl Martin (CIK 1362155) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-25). Recent activity: Sell ALLO (29,697 shares), Sell ALLO (22,900 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | Allogene Therapeutics, Inc. (ALLO) | SVP, General Counsel | Sell | 29,697 | $62,958 |
| 2026-02-04 | Allogene Therapeutics, Inc. (ALLO) | SVP, General Counsel | Sell | 22,900 | $40,304 |
来源：SEC Form 4 申报文件 · 截至 2026-08-25